Number of drug approvals for rare diseases 1970-2010
This statistic shows the number of drug approvals for rare diseases in the United States between 1970 and 2010.
Number of drug approvals for rare diseases in the U.S. between 1970 and 2010
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Orphan drugs
Rare diseases
4
- Basic Statistic Prevalence of selected rare diseases worldwide 2017
- Basic Statistic Overview of rare diseases worldwide and in the U.S. as of 2016
- Premium Statistic Impact of medicines on life expectancy for select rare diseases worldwide as of 2017
- Basic Statistic Distribution of U.S. patients with rare factor deficiencies as of 2024, by gender
Market overview
5
- Basic Statistic Projection of global revenue for orphan prescription drugs 2016-2028
- Premium Statistic Price comparison of most expensive drugs U.S. 2023
- Basic Statistic Worldwide share of orphan drug sales by therapy category 2023 vs. 2028
- Basic Statistic Global rare disease diagnostics market size 2019 and 2030
- Basic Statistic Global rare disease diagnostics market size 2019 and 2030 by therapy area
Companies
4
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2023
- Premium Statistic Top global companies by orphan drug revenues 2023
- Premium Statistic Top 10 companies by global revenue from orphan drugs 2028
- Basic Statistic Orphan drugs sales share among top pharma companies 2028 forecast
Products
6
- Premium Statistic Projection of top orphan drugs by global revenue 2028
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Basic Statistic Oncology or orphan drug share in approved new active substances 2015-2022
- Premium Statistic FDA approved orphan drugs with non-orphan indications 1983-2018
- Basic Statistic Share of new orphan drugs available in Europe in 2024, by country
- Basic Statistic Time between orphan drugs approval and patient access in Europe 2024, by country
Research and development
6
- Premium Statistic Total global pharmaceutical R&D spending 2014-2030
- Premium Statistic Total rare diseases funding by the National Institutes for Health 2013-2025
- Basic Statistic Orphan and non-orphan drugs in the pipeline worldwide 2021
- Basic Statistic Leading orphan drugs in development based on net present value 2024
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Premium Statistic U.S. development Phase success rates for rare and common disease drugs 2011-2020
Further related statistics
9
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- CVS Health's total assets 2005-2023
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
Further Content: You might find this interesting as well
Statistics
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- CVS Health's total assets 2005-2023
- Global pharmaceutical pipeline by therapy area 2013-2017
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- Johnson & Johnson's number of employees 2004-2023
- Annual revenue of Sinopharm 2010-2022
- Number of employees at Sinopharm 2011-2022
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
PhRMA. (April 30, 2012). Number of drug approvals for rare diseases in the U.S. between 1970 and 2010 [Graph]. In Statista. Retrieved November 03, 2024, from https://www.statista.com/statistics/215453/number-of-drug-approvals-for-rare-diseases/
PhRMA. "Number of drug approvals for rare diseases in the U.S. between 1970 and 2010." Chart. April 30, 2012. Statista. Accessed November 03, 2024. https://www.statista.com/statistics/215453/number-of-drug-approvals-for-rare-diseases/
PhRMA. (2012). Number of drug approvals for rare diseases in the U.S. between 1970 and 2010. Statista. Statista Inc.. Accessed: November 03, 2024. https://www.statista.com/statistics/215453/number-of-drug-approvals-for-rare-diseases/
PhRMA. "Number of Drug Approvals for Rare Diseases in The U.S. between 1970 and 2010." Statista, Statista Inc., 30 Apr 2012, https://www.statista.com/statistics/215453/number-of-drug-approvals-for-rare-diseases/
PhRMA, Number of drug approvals for rare diseases in the U.S. between 1970 and 2010 Statista, https://www.statista.com/statistics/215453/number-of-drug-approvals-for-rare-diseases/ (last visited November 03, 2024)
Number of drug approvals for rare diseases in the U.S. between 1970 and 2010 [Graph], PhRMA, April 30, 2012. [Online]. Available: https://www.statista.com/statistics/215453/number-of-drug-approvals-for-rare-diseases/